Wellington Management Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-85,483
Closed -$1.58M 1926
2025
Q3
$1.58M Sell
85,483
-26,424
-24% -$424K ﹤0.01% 1696
2025
Q2
$1.46M Buy
111,907
+19,033
+20% +$225K ﹤0.01% 1650
2025
Q1
$984K Sell
92,874
-4,162
-4% -$66.1K ﹤0.01% 1712
2024
Q4
$1.65M Buy
97,036
+742
+0.8% +$14K ﹤0.01% 1618
2024
Q3
$2.23M Sell
96,294
-264,455
-73% -$5.66M ﹤0.01% 1518
2024
Q2
$8.78M Buy
360,749
+75,634
+27% +$2.29M ﹤0.01% 1188
2024
Q1
$9.63M Buy
285,115
+224,274
+369% +$7.95M ﹤0.01% 1145
2023
Q4
$1.92M Buy
60,841
+17,491
+40% +$416K ﹤0.01% 1505
2023
Q3
$1.11M Buy
43,350
+1,098
+3% +$33.8K ﹤0.01% 1593
2023
Q2
$1.21M Sell
42,252
-1,608
-4% -$43.8K ﹤0.01% 1577
2023
Q1
$1.05M Sell
43,860
-115
-0.3% -$2.06K ﹤0.01% 1645
2022
Q4
$746K Sell
43,975
-249
-0.6% -$4.34K ﹤0.01% 1717
2022
Q3
$655K Sell
44,224
-12,124
-22% -$203K ﹤0.01% 1727
2022
Q2
$887K Buy
56,348
+75
+0.1% +$1.47K ﹤0.01% 1699
2022
Q1
$1.52M Buy
56,273
+5,483
+11% +$140K ﹤0.01% 1657
2021
Q4
$1.88M Buy
+50,790
New +$2.07M ﹤0.01% 1686

Other funds holding ARCT

Wellington Management Group's ARCT Position: Q4 2025 in Review

Wellington Management Group sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 85,483 shares — an estimated $1.58M sold.

Wellington Management Group first reported a position in ARCT in Q4 2021 and held it in 16 quarters. The position peaked at $9.63M in Q1 2024. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.

  • Wellington Management Group reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Wellington Management Group sold 85,483 Arcturus Therapeutics shares in Q4 2025, an estimated $1.58M.
  • Wellington Management Group first reported a position in Arcturus Therapeutics in Q4 2021 and held it in 16 quarters.
  • Wellington Management Group's Arcturus Therapeutics position peaked at $9.63M in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.

Based on Wellington Management Group's 13F filing for Q4 2025, filed 17 Feb 2026.